INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

1,226 studies · page 7 of 52

2018 / Randomized double-blind controlled trial

A mixed herbal supplement of fenugreek, ginger, and turmeric significantly increased milk volume in breastfeeding mothers compared to placebo.

Fifty exclusively breastfeeding mothers were randomized to receive either a mixed herbal supplement (fenugreek, ginger, and turmeric; three capsules three times daily) or a placebo for 4 weeks. Mothers receiving the herbal supplement experienced a 49% increase in milk volume at week 2 and a 103% increase at week 4, which were significantly greater than increases in the placebo group (p < 0.05). There were no differences in milk nutrient content or observed adverse effects between the two groups.

Bumrungpert A, Somboonpanyakul P, Pavadhgul P, et al. Breastfeed Med, 2018. PMID 30411974

2018 / Dietary intervention study

Increased dietary fiber intake was linked to decreased zonulin in fatty liver disease.

In a 6-month dietary intervention among 32 individuals with nonalcoholic fatty liver disease, average daily fiber intake rose from 19 g to 29 g. Serum zonulin dropped by nearly 90% (7.335 vs. 0.507 ng/mL, P = 0.001) and was correlated with fiber intake (P = 0.043) and steatosis grade (P = 0.037). Participants also displayed significant improvements in liver enzymes, triglycerides (P = 0.036), HOMA-IR (P = 0.041), and fatty liver score (P = 0.009).

Krawczyk M, Maciejewska D, Ryterska K, et al. Nutrients, 2018. PMID 30453660

2018 / Randomized controlled trial

Nut intake improves semen quality parameters and reduces DNA fragmentation in young men.

A 14-week randomized parallel trial in 119 healthy men eating a Western diet evaluated adding 60 g/day of mixed nuts versus abstaining from nuts. Nut supplementation significantly enhanced total sperm count (P = 0.002), vitality (P = 0.003), overall motility (P = 0.006), progressive motility (P = 0.036), and cellular morphology (P = 0.008). The nut group also showed lower sperm DNA fragmentation (P < 0.001) and decreased miR-34b-3p expression.

Salas-Huetos A, Moraleda R, Giardina S, et al. Am J Clin Nutr, 2018. PMID 30475967

2018 / Non-randomized controlled trial

Gastrointestinal symptoms were more frequent with higher doses of D-allulose in adults

In a non-randomized controlled trial, young adults underwent gastrointestinal tolerance tests with stepwise dose escalations of D-allulose. No severe diarrhea or gastrointestinal symptoms appeared up to 0.4 g/kg body weight, but severe diarrhea occurred at 0.5 g/kg body weight. Compared to sugar, D-allulose was linked to higher frequencies of diarrhea (p = 0.004), abdominal distention (p = 0.039), and abdominal pain (p = 0.031), while escalating total daily intake to 1.0 g/kg body weight produced severe nausea, headache, anorexia, and diarrhea.

Han Y, Choi BR, Kim SY, et al. Nutrients, 2018. PMID 30572580

2017 / Randomized controlled trial

Personalized nutrition advice promoted greater dietary improvements than standard advice in European adults.

Adults from seven European countries were randomized to conventional dietary advice or personalized nutrition advice based on diet, phenotype, or genotype. Among 1,269 participants completing the 6-month trial, personalized nutrition reduced intake of red meat (-5.48 g, 95% CI: -10.8 to -0.09, P = 0.046), salt (-0.65 g, 95% CI: -1.1 to -0.25, P = 0.002), and saturated fat (-1.14% of energy, P < 0.0001), while raising Healthy Eating Index scores (1.27, P = 0.010). Adding phenotypic or genotypic data did not enhance effectiveness.

Celis-Morales C, Livingstone KM, Marsaux CF, et al. Int J Epidemiol, 2017. PMID 27524815

2017 / Comparative crossover trial

A menthol mouthwash reduced food wanting, liking, and ad libitum intake of potato crisps by 29%.

Researchers evaluated the effect of no mouthwash, a water mouthwash, and a menthol mouthwash on crisp aftertaste perception and appetite. In the appetite study with 36 subjects, the water mouthwash did not alter desire, liking, hunger, thirst, or ad libitum intake. In contrast, the menthol mouthwash significantly reduced crisp desire, liking, hunger, and thirst, and lowered ad libitum crisp intake by 29% over a 12-minute period.

Hutchings SC, Horner KM, Dible VA, et al. Appetite, 2017. PMID 27663531

2017 / Randomized crossover trial

Coconut water did not improve hydration markers or cycling time trial performance.

In a randomized crossover trial, 10 males completed 60 minutes of submaximal cycling followed by a 10-km time trial while consuming plain water or coconut water. Time trial performance did not significantly differ between coconut water and plain water (971.4 ± 50.5 versus 966.6 ± 44.8 seconds, p = .698). Voluntary intake was lower with coconut water (115 ± 95.41 ml versus 208.7 ± 86.22 ml, p < .001).

Peart DJ, Hensby A, Shaw MP Int J Sport Nutr Exerc Metab, 2017. PMID 27768399

2017 / Crossover trial

Adding 30 g of insoluble dietary fiber to a high-fat high-calorie meal reduced postprandial inflammatory and ROS responses in normal fasting subjects.

Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.

Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549

2017 / Randomized crossover trial

Non-nutritive sweeteners did not reduce total daily energy intake compared with sucrose.

A randomized crossover trial in 30 healthy men compared mid-morning preloads sweetened with aspartame, monk fruit, stevia, or sucrose (65 g). Ad libitum lunch intake was higher after non-nutritive sweetener drinks than sucrose (P = 0.010), leading to full compensation and no difference in total daily energy intake (P = 0.831). Three-hour total area under the curve for glucose (P = 0.960) and insulin (P = 0.216) did not differ among the four beverages.

Tey SL, Salleh NB, Henry J, et al. Int J Obes (Lond), 2017. PMID 27956737

2017 / Randomized controlled crossover trial

Both Salba-chia and flax seeds lowered postprandial blood glucose, but Salba-chia altered peak glucose kinetics and reduced appetite more than flax.

Fifteen healthy participants received a 50 g glucose challenge alone or supplemented with either 25 g ground Salba-chia or 31.5 g flax on three separate occasions. Both Salba-chia and flax reduced the 120-min blood glucose area under the curve by 82.5±19.7 mmol/l (P<0.001) and 60.0±19.7 mmol/l (P=0.014), respectively, relative to control. Compared with flax, Salba-chia reduced peak glucose by -0.64±0.24 mmol/l (P=0.030), increased time to peak by 11.3±3.8 min (P=0.015), and significantly reduced overall appetite score (-6±2 mm; P=0.012). Viscosity was 49.9 Pa·s for Salba-chia, 2.5 Pa·s for flax, and 0.002 Pa·s for control.

Vuksan V, Choleva L, Jovanovski E, et al. Eur J Clin Nutr, 2017. PMID 28000689

2017 / Randomized crossover trial

Adding freeze-dried strawberry powder to a high-fat meal did not alter postprandial vascular markers.

A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).

Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205

2017 / Controlled dietary trial

A ketogenic low-carbohydrate, high-fat diet impaired exercise economy and negated 10 km race walk performance benefits compared to high-carbohydrate diets.

Elite race walkers underwent 3 weeks of intensified training while adhering to one of three isoenergetic diets: high carbohydrate availability (HCHO), periodised carbohydrate (PCHO), or a ketogenic low-carbohydrate, high-fat diet (LCHF). Following the intervention, VO2 peak increased in all groups (P < 0.001). LCHF markedly increased whole-body fat oxidation (peak rates of 1.57 ± 0.32 g min-1 at ~80% VO2 peak) but increased the oxygen cost of race walking. While HCHO and PCHO groups improved 10 km race walk times by 6.6% and 5.3% respectively, the LCHF group showed no improvement (-1.6%), negating performance gains due to reduced exercise economy.

Burke LM, Ross ML, Garvican-Lewis LA, et al. J Physiol, 2017. PMID 28012184

2017 / 12-week double-blind randomized placebo-controlled trial

Vitamin B-12-fortified toothpaste significantly improved vitamin B-12 markers over 12 weeks in vegans.

A 12-week double-blind trial randomized 76 vegans to use either placebo or vitamin B-12-fortified toothpaste (66 completed). Changes over 12 weeks were higher in the vitamin B-12 group than placebo for vitamin B-12 (mean ± SD change: 81 ± 135 vs. -27 ± 64 pmol/L) and holotranscobalamin (26 ± 34 vs. -5 ± 17 pmol/L) after baseline adjustment. Methylmalonic acid (MMA) changes differed significantly (-0.169 ± 0.340 vs. -0.036 ± 0.544 μmol/L; P < 0.001), while postintervention total homocysteine tended to be lower (P = 0.051; change of -0.7 ± 4.4 vs. 2.0 ± 5.6 μmol/L). Changes were more prominent in vegans not taking vitamin B-12 supplements.

Siebert AK, Obeid R, Weder S, et al. Am J Clin Nutr, 2017. PMID 28052884

2017 / Randomized controlled trial

In women who do not habitually eat breakfast, adding breakfast for four weeks increased daily caloric intake and led to modest weight gain.

Forty-nine nonhabitual breakfast-eating women were randomized for four weeks to either consume breakfast (at least 15% of daily energy requirement before 8:30 a.m.) or skip breakfast (no energy intake until after 11:30 a.m.). Participants assigned to eat breakfast consumed on average 266 ± 496 more calories per day (P < 0.01) and weighed 0.7 ± 0.8 kg more at the end of the intervention (p < 0.01). No caloric compensation was observed at subsequent meals, and there were no changes in self-reported hunger, satiety, or physical activity compensation.

LeCheminant GM, LeCheminant JD, Tucker LA, et al. Appetite, 2017. PMID 28063876

2017 / Randomized controlled trial

An acute saturated fat load induced insulin resistance and increased hepatic lipid storage.

A randomized trial in 14 lean, healthy individuals evaluated the metabolic impacts of an oral palm oil challenge compared with vehicle. Palm oil lowered insulin sensitivity across the whole body by 25%, liver by 15%, and adipose tissue by 34%. It also boosted liver triglyceride stores by 35%, increased ATP levels by 16%, and elevated gluconeogenesis by 70%, while decreasing glycogenolysis by 20%.

Hernández EÁ, Kahl S, Seelig A, et al. J Clin Invest, 2017. PMID 28112681

2017 / Randomized controlled trial

Post-meal exercise heightened airway inflammation regardless of habitual physical activity level.

A trial assessed airway inflammation following a high-fat meal in 58 nonasthmatic adults (39 active and 19 insufficiently active). Participants were randomized to either 1 hour of treadmill exercise or remaining sedentary after eating. Across all participants, exhaled nitric oxide rose at 2 hours and returned to baseline by 4 hours (p = 0.03), with exercisers exhibiting higher exhaled nitric oxide at 4 hours than sedentary controls (p = 0.04).

Kurti SP, Rosenkranz SK, Chapes SK, et al. Appl Physiol Nutr Metab, 2017. PMID 28121185

2017 / Randomized crossover trial

Short-term carbohydrate overfeeding, without protein restriction, markedly increased circulating FGF21 levels in healthy men.

Nine healthy men were fed three diets for three days each in random order: a eucaloric control diet (CON), a carbohydrate-rich diet (+75% energy, 80 E% carbohydrate; CHO), and a fat-rich diet (+75% energy, 78 E% fat; FAT), maintaining similar absolute protein intake between CHO and CON. Plasma FGF21 increased 8-fold after CHO compared to CON (329 ± 99 vs. 39 ± 9 pg ml-1, p < 0.05), whereas FAT produced only a non-significant tendency to increase (p = 0.073). The increase in FGF21 after CHO correlated closely (r = 0.88, p < 0.01) with increased leg glucose uptake (62%, p < 0.05) and hepatic glucose production (17%, p < 0.01). CHO also decreased plasma fatty acids by 68% (p < 0.01), increased the de novo lipogenesis marker C16:1 n-7 FA by 146% (p < 0.01), and increased plasma triglycerides by 101% (p < 0.001).

Lundsgaard AM, Fritzen AM, Sjøberg KA, et al. Mol Metab, 2017. PMID 28123934

2017 / Interventional trial with wash-out period

Chronic branched chain amino acid supplementation impaired insulin sensitivity in vegans but not in omnivores.

Eight vegans and eight matched omnivores were supplemented with 15 g (women) or 20 g (men) of branched chain amino acids (BCAA) daily for 3 months, followed by a 6-month wash-out. Vegans had higher baseline insulin sensitivity (GIR: 9.6±2.4 vs 7.1±2.4 mg/kg/min), which declined following the intervention (change: -1.64 mg/kg/min [95% CI: -2.5 to -0.75]) and returned to baseline after wash-out (change: 1.65 mg/kg/min [95% CI: 0.75 to 2.54]). No GIR change was observed in omnivores, though omnivores showed increased expression of lipogenic genes in adipose tissue. Skeletal muscle respiratory chain activity increased in both groups.

Gojda J, Rossmeislová L, Straková R, et al. Eur J Clin Nutr, 2017. PMID 28145418

2017 / Randomized, placebo-controlled, double-blind parallel trial

Resveratrol supplementation for 16 weeks did not improve metabolic syndrome markers and high doses increased total and LDL cholesterol.

A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.

Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820

2017 / Double-blind, parallel, randomized placebo-controlled trial

Encapsulated fruit and vegetable juice concentrate reduced total cholesterol, LDL cholesterol, and plasma TNFα, and increased lean mass in overweight/obese adults.

A double-blind, parallel, randomized placebo-controlled trial examined the effects of eight weeks of daily supplementation with six capsules of fruit and vegetable juice concentrate or placebo in 56 overweight and obese adults aged ≥40 years. Following consumption of the juice concentrate, total cholesterol, LDL cholesterol, and plasma TNFα decreased and total lean mass increased, with no change in the placebo group. In participants with high baseline systemic inflammation (serum CRP ≥3.0 mg/mL, n = 16), these effects were greater, though plasma CRP remained unchanged. The concentrate also altered the expression of genes involved in lipogenesis, NF-κB, and AMPK signalling pathways, such as PMVK, ZFAND5, and CAB39.

Williams EJ, Baines KJ, Berthon BS, et al. Nutrients, 2017. PMID 28208713

2017 / Randomized, double-blind, placebo-controlled trial

Prebiotic supplementation improved subjective appetite control and reduced breakfast buffet energy intake in older children with overweight or obesity.

Forty-two children aged 7-12 years with BMI >=85th percentile were randomized to receive 8 g/d of oligofructose-enriched inulin or maltodextrin placebo for 16 weeks. Compared with placebo, prebiotics led to significantly higher fullness (P = 0.04) and lower prospective food consumption (P = 0.03) at a week 16 breakfast buffet, and significantly reduced energy intake in 11- to 12-year-olds (P = 0.04) but not 7- to 10-year-olds. Fasting adiponectin (P = 0.04) and ghrelin (P = 0.03) significantly increased with prebiotics compared to placebo. Prebiotic supplementation showed a trend toward reducing BMI z score in intent-to-treat analysis (-3.4%; P = 0.09) and a significant -3.8% reduction in per-protocol analysis (P = 0.043).

Hume MP, Nicolucci AC, Reimer RA Am J Clin Nutr, 2017. PMID 28228425

2017 / Randomized controlled trial

Advice to drink 8 cups of water per day did not improve weight loss in adolescents with overweight or obesity compared to diet alone.

Thirty-eight adolescents with overweight or obesity receiving a weight-reducing intervention were randomized to receive additional advice and behavioral support to drink 8 cups of water per day or no water advice. At 6 months, self-reported water intake increased more in the water group (difference between groups, 1.6 cups per day [95% CI, 0.2 to 3.0]; P = .03). However, the 6-month change in body mass index z score did not differ between the water group and the control group (between-group difference, -0.0 [95% CI, -0.1 to 0.1]; P = .88). Despite intensive behavioral supports, few adolescents met the 8 cups per day target.

Wong JMW, Ebbeling CB, Robinson L, et al. JAMA Pediatr, 2017. PMID 28264082

2017 / Randomised, double-blind, placebo-controlled crossover trial

Once-weekly semaglutide reduced daily ad libitum energy intake by 24% and reduced body weight by 5.0 kg over 12 weeks in subjects with obesity.

In a randomised, double-blind, placebo-controlled crossover trial, 30 subjects with obesity received 12 weeks of once-weekly subcutaneous semaglutide (dose-escalated to 1.0 mg) or placebo. Semaglutide led to a lower ad libitum energy intake during lunch (-1255 kJ; P < .0001), the evening meal (P = .0401), and snacks (P = .0034), producing a 24% reduction in total daily ad libitum energy intake (-3036 kJ; P < .0001). Semaglutide also improved fasting appetite suppression scores, reduced hunger, cravings, and preference for high-fat foods, and reduced mean body weight by 5.0 kg predominantly from fat mass, with no difference in lean-mass-adjusted resting metabolic rate.

Blundell J, Finlayson G, Axelsen M, et al. Diabetes Obes Metab, 2017. PMID 28266779

2017 / Randomized two-way crossover trial

A single night of bright light exposure significantly increased post-meal plasma glucose and insulin levels compared to dim light in healthy participants.

Seventeen healthy participants were randomized to a two-way crossover study comparing dim light (<5 lux) and bright light (>500 lux) sessions separated by at least 7 days, measuring metabolic responses around a standard evening meal. Plasma glucose and insulin levels were significantly higher post-meal during bright light compared to dim light (P = 0.02 and P = 0.001, respectively). Pre-meal plasma non-esterified fatty acid levels and salivary melatonin were significantly higher in dim light compared to bright light (P < 0.01 and P = 0.005, respectively), while plasma triglyceride levels did not differ between sessions.

Albreiki MS, Middleton B, Hampton SM Endocr Connect, 2017. PMID 28270559